Loomis, Sayles & Company’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
+1,044,992
| New | +$17.5M | 0.02% | 262 |
|
|
2017
Q1 | – | Sell |
-1,170,319
| Closed | -$42.4M | – | 1032 |
|
|
2016
Q4 | $42.4M | Buy |
1,170,319
+145,365
| +14% | +$5.27M | 0.1% | 125 |
|
|
2016
Q3 | $47.2M | Sell |
1,024,954
-8,626
| -0.8% | -$397K | 0.12% | 98 |
|
|
2016
Q2 | $51.9M | Sell |
1,033,580
-55,425
| -5% | -$2.78M | 0.14% | 92 |
|
|
2016
Q1 | $58.3M | Buy |
1,089,005
+98,352
| +10% | +$5.26M | 0.17% | 84 |
|
|
2015
Q4 | $65M | Buy |
990,653
+68,357
| +7% | +$4.49M | 0.18% | 76 |
|
|
2015
Q3 | $52.1M | Sell |
922,296
-104,941
| -10% | -$5.92M | 0.15% | 101 |
|
|
2015
Q2 | $60.7M | Sell |
1,027,237
-61,141
| -6% | -$3.61M | 0.17% | 106 |
|
|
2015
Q1 | $67.8M | Buy |
1,088,378
+36,257
| +3% | +$2.26M | 0.19% | 100 |
|
|
2014
Q4 | $60.5M | Sell |
1,052,121
-141,161
| -12% | -$8.12M | 0.17% | 117 |
|
|
2014
Q3 | $64.1M | Buy |
1,193,282
+108,253
| +10% | +$5.82M | 0.19% | 113 |
|
|
2014
Q2 | $56.9M | Buy |
1,085,029
+437,833
| +68% | +$23M | 0.16% | 136 |
|
|
2014
Q1 | $34.2M | Buy |
647,196
+644,908
| +28,187% | +$34.1M | 0.1% | 202 |
|
|
2013
Q4 | $92K | Hold |
2,288
| – | – | ﹤0.01% | 694 |
|
|
2013
Q3 | $86K | Hold |
2,288
| – | – | ﹤0.01% | 678 |
|
|
2013
Q2 | $90 | Buy |
+2,288
| New | +$90 | ﹤0.01% | 673 |
|